Ann: Initial Director's Interest Notice - A. Chapman, page-8

Good snapshot on Germany - its a very interesting market and getting more interesting from Jan 1st 2024 when Medical Cannabis is de-scheduled from a Narcotic to a Drug. This will make it a lot easier for Doctors to prescribe and demand should increase similar to that we have seen in Oz.

In terms of Full Time vs Part Time - there are no full time employees on the payroll in AC8 any longer and at the moment there are none required. This will change with the next steps of the company but for now we are preferring to keep costs low.

Newvis was an AC8 technology not something that was bought in, that whilst it ultimately didn't fail - there was minimal adoption of and therefore the cost per unit was prohibitive to the industry that was moving very quickly towards Medical/Recreational delivery methods using flower vs oil or powder.